A clear understanding of the complex, ever-changing antiretroviral (ARV) and diagnostic markets in low- and middle-income countries is critical for all stakeholders in the HIV space. To address this need, CHAI publishes an annual HIV market report for public...
CHAI’s HIV Market Report provides a global perspective on the ARV marketplace in low- and middle-income countries in 2017 and outlines CHAI’s expectations on how the market will evolve over the next five years. Read the report here: 2018 HIV Market...
After five hours hunched in a crowded minibus, three hours trying to soothe a crying baby, and one hour waiting to see a healthcare worker, she had made it. This Malawian mother had finally made it to a health facility to test her baby for HIV. Despite the hours of...
Seventeen years: This is how long it typically takes for a scientifically tested intervention to be integrated into standard practice, according to experts. But can this gap between research and policy be closed? Health sector stakeholders in Rwanda are trying to do...
In 2015, HIV was the cause of 19 percent of all childhood deaths under the age of five in Lesotho. Previous strategies to identify and treat children who were living with HIV had proven ineffective and Lesotho’s goal to reach 80 percent of children living with HIV had...
As we welcome another World Hepatitis Day, the global response to eliminate viral hepatitis as a public threat is accelerating. Viral hepatitis, consisting of hepatitis B (HBV) and hepatitis C (HCV), affects more than 320 million people worldwide, with 90 percent of...
Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the...
We are delighted to announce the joint launch of a partnership to speed up development and introduction of optimized pediatric formulations of dolutegravir for children living with HIV in resource-limited settings. The new initiative includes an incentive program and...
In Vietnam, a million people are infected with Hepatitis C (HCV). Without treatment, HCV can cause cirrhosis, liver cancer and even death. While no vaccines exist to prevent HCV, the virus is easily treated with directly-acting antivirals (DAAs). In 2017, CHAI worked...
Introducing the second edition of CHAI’s HIV Mid-Year Market Memo, an informational brief that covers the latest trends in the HIV space in low- and middle-income countries (LMICs) since the publication of CHAI’s annual ARV Market Report in September 2017. See the HIV...
